Ha C - Search Results

1

Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC Consortium.

Fenster M, Alayo QA, Khatiwada A, Wang W, Dimopoulos C, Gutierrez A, Ciorba MA, Christophi GP, Hirten RP, Ha C, Beniwal-Patel P, Cohen BL, Syal G, Yarur A, Patel A, Colombel JF, Pekow J, Ungaro RC, Rubin DT, Deepak P. Fenster M, et al. Among authors: ha c. Clin Gastroenterol Hepatol. 2021 Oct;19(10):2207-2209.e3. doi: 10.1016/j.cgh.2020.10.025. Epub 2020 Oct 14. Clin Gastroenterol Hepatol. 2021. PMID: 33068786 Free PMC article.

2

Risk of arterial thrombotic events in inflammatory bowel disease.

Ha C, Magowan S, Accortt NA, Chen J, Stone CD. Ha C, et al. Am J Gastroenterol. 2009 Jun;104(6):1445-51. doi: 10.1038/ajg.2009.81. Epub 2009 Apr 21. Am J Gastroenterol. 2009. PMID: 19491858

3

Probiotics as therapy in gastroenterology: a study of physician opinions and recommendations.

Williams MD, Ha CY, Ciorba MA. Williams MD, et al. J Clin Gastroenterol. 2010 Oct;44(9):631-6. doi: 10.1097/MCG.0b013e3181d47f5b. J Clin Gastroenterol. 2010. PMID: 20216432 Free PMC article.

4

Patients with late-adult-onset ulcerative colitis have better outcomes than those with early onset disease.

Ha CY, Newberry RD, Stone CD, Ciorba MA. Ha CY, et al. Clin Gastroenterol Hepatol. 2010 Aug;8(8):682-687.e1. doi: 10.1016/j.cgh.2010.03.022. Epub 2010 Apr 2. Clin Gastroenterol Hepatol. 2010. PMID: 20363368 Free PMC article.

5

Thiopurine therapy in inflammatory bowel disease.

Ha C, Dassopoulos T. Ha C, et al. Expert Rev Gastroenterol Hepatol. 2010 Oct;4(5):575-88. doi: 10.1586/egh.10.59. Expert Rev Gastroenterol Hepatol. 2010. PMID: 20932143 Review.

6

Magnetic resonance enterography: safe and effective imaging for stricturing Crohn's disease.

Ha CY, Kumar N, Raptis CA, Narra VR, Ciorba MA. Ha CY, et al. Dig Dis Sci. 2011 Oct;56(10):2906-13. doi: 10.1007/s10620-011-1781-0. Epub 2011 Jun 19. Dig Dis Sci. 2011. PMID: 21688128 Free PMC article.

7

Patients enrolled in randomized controlled trials do not represent the inflammatory bowel disease patient population.

Ha C, Ullman TA, Siegel CA, Kornbluth A. Ha C, et al. Clin Gastroenterol Hepatol. 2012 Sep;10(9):1002-7; quiz e78. doi: 10.1016/j.cgh.2012.02.004. Epub 2012 Feb 15. Clin Gastroenterol Hepatol. 2012. PMID: 22343692

8

Immunosuppressive therapy does not increase operative morbidity in patients with Crohn's disease.

Bafford AC, Powers S, Ha C, Kruse D, Gorfine SR, Chessin DB, Bauer JJ. Bafford AC, et al. Among authors: ha c. J Clin Gastroenterol. 2013 Jul;47(6):491-5. doi: 10.1097/MCG.0b013e3182677003. J Clin Gastroenterol. 2013. PMID: 23090048

9

Clinical presentation and outcomes of inflammatory bowel disease patients admitted to the intensive care unit.

Ha C, Maser EA, Kornbluth A. Ha C, et al. J Clin Gastroenterol. 2013 Jul;47(6):485-90. doi: 10.1097/MCG.0b013e318275d981. J Clin Gastroenterol. 2013. PMID: 23388843

10

Clinical implications of ageing for the management of IBD.

Ha CY, Katz S. Ha CY, et al. Nat Rev Gastroenterol Hepatol. 2014 Feb;11(2):128-38. doi: 10.1038/nrgastro.2013.241. Epub 2013 Dec 17. Nat Rev Gastroenterol Hepatol. 2014. PMID: 24345890 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,253 results

Search Page